MISPA-i2 uses the Nephelometric technology for specific protein determination and supports the clinical management of a variety of disease states, such as cardiovascular risk, rheumatoid diseases Benefits Best sensitivity and Linearity due to Nephelometry and immune-Turbidimetry channel Freedom to perform special parameters Fast and accurate results with minimum TAT and less interference Highly Cost effectiveness reagents User friendly Procuedure Easy reproducibility of results